# ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer

> **NCT04943484** · — · RECRUITING · sponsor: **Niguarda Hospital** · enrollment: 360 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **PROCEDURE:** imaging fluorescence NIR/ICG

## Key facts

- **NCT ID:** NCT04943484
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2024-08-31
- **Final completion:** 2026-11-30
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04943484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04943484, "ICG (Indocyanine Green) Imaging Fluorescence Technology in Surgical Treatment of Advanced Gastric Cancer". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04943484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*